Status:
COMPLETED
Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery
Lead Sponsor:
Baskent University
Conditions:
Chronic Renal Failure
Hip Fracture
Eligibility:
All Genders
65-95 years
Phase:
PHASE3
Brief Summary
Geriatric patients (age ≥ 65 years) undergo surgery for hip fractures that develops due to osteoporosis and falls. Dialysis-dependent chronic kidney disease is associated with an increased risk of car...
Detailed Description
Patients will be randomized into two separate groups.Group Dexmedetomidine (Group D): Midazolam 0.02 mg/kg + 0.5 μg/kg/10 min dexmedetomidine infusion for premedication; Spinal block (Hyperbaric bupiv...
Eligibility Criteria
Inclusion
- elderly patients (above 65 years of age)
- end stage renal failure on dialysis treatment (Glomerular filtration rate \<15, Stage 5)
- hip fracture
Exclusion
- Patients with decompensated respiratory or heart failure,
- liver failure
- morbid obesity
- mental disorders
- cognitive disorders
- language problems
- patients with a contraindication for regional anesthesia (coagulopathy, history of anticoagulant use, spinal cord disease and patients who rejected spinal anesthesia)
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01837290
Start Date
December 1 2012
End Date
January 1 2014
Last Update
January 27 2015
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Baskent University School of Medicine Adana Research and Teaching Center
Adana, Turkey (Türkiye), 01250
2
Baskent University School of Medicine Adana Teaching and Research Center
Adana, Turkey (Türkiye), 01250
3
Baskent University School of Medicine Adana Teaching and Research Hospital
Adana, Turkey (Türkiye), 01250